Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Antibody Engineering & Therapeutics Asia
19 - 21 October, 2026
The Westin Miyako KyotoKyoto, Japan

Fortunato Ferrara
Vice President of Discovery at IQVIA, USA
Speaker

Profile

Fortunato Ferrara, PhD is Vice President of Discovery at Specifica, an IQVIA business, where he leads antibody discovery and engineering programs spanning target assessment, lead generation, affinity maturation, and preclinical candidate selection. With more than 15 years of experience in therapeutic antibody discovery, he has pioneered next-generation antibody library technologies and advanced multiple programs in oncology, immunology, infectious disease, and respiratory disease. Dr. Ferrara is an expert in antibody engineering, developability optimization, and AI-driven antibody optimization. He is an inventor on multiple therapeutic antibody patents and has authored more than 50 peer-reviewed publications.

Agenda Sessions

  • Antibody discovery strategies for challenging targets

    16:00